Journalist covering life sciences, healthcare and banking. pallavi86@gmail.com
LongRead: Bellary is known for the indiscriminate mining. What happened to the conservation areas in a land that is shaped like a bowl?
Thesis published in IIJNM / April 2012
What if aspirin could improve lifespan or quality of life? What if an expensive drug is offered for free? What if none of these can happen? BUT, also, what if all of these seemingly beneficial acts are not so?
The Financial Express / January 2015
What do you do when you know that bankers are going to come raiding your till? You buy a Lamborghini Huracan coupe, a Mercedes Benz S350 and a BMW Z4 sDrive
The Financial Express / July 2015
When a stock rose 416% in four months
The Financial Express / August 2015
“It is a non-compliance but what is the concern? Every non-compliance is not a concern." - MD
The Financial Express / June 2015
First hint of trouble in Alok Ind. which has foreign lenders seeking court-led liquidation now
The Financial Express / April 2015
What happened when Sun Pharma had a run-in with the U.S. FDA
The Financial Express / November 2014
Company official impeded inspection, documents from U.S. FDA shows
The Financial Express / May 2014
Strategic investor rescue, with strings attached
The Financial Express / June 2015
Dull business environment = nil business = refinance mantra = undercut, undercut, undercut
The Financial Express / July 2015
Despite SDR being introduced in a circular, RBI was yet to notify it. This was the first time RBI acknowledged that banks can use the scheme
The Financial Express / June 2015
One of the examples where 5/25 was employed in a viable project
The Financial Express / June 2015
Bankers have cleared three loan refinancing proposals worth 25,000 crore under the 5/25 scheme — those of the financially-stressed Jaypee Infratech, Adani Power and Uttam Galva Metallics.
The Financial Express / May 2015
An SDR, before SDR came into being
The Financial Express / April 2015
In an ‘exceptional occurrence’, the Reserve Bank of India (RBI) reportedly wrote to bankers in January, pointing out large-scale irregularities and misappropriation by loss-making Basmati rice exporter REI Agro.
The Financial Express / March 2015
Indian and foreign generic drug makers seem to focus increasingly on the relatively fast-growing injectables segment to ramp up their revenues.
The Financial Express / March 2014
Generic drug players like Natco Pharma and Lupin are finding it tough to launch new products, as innovator companies offer different versions of existing drugs before patent expiry, in effect prolonging the patent period and stymieing plans to launch copy
The Financial Express / April 2014
Over the last 15 years or so, several of them, including Glenmark, Biocon Cadila Healthcare, Dr Reddys Laboratories, have put in the time and resources to try and discover some blockbuster drug or other but their efforts havent paid off.
The Financial Express / June 2014
Clinical trials are picking up pace with 76 trials having got a no-objection certificate till May 2014, more than three times the number in the corresponding period of 2013.
The Financial Express / August 2014
With $32 billion worth of drugs going off patent in the next two years, Indian pharma companies are going all out to launch generics in the US market
The Financial Express / March 2014
Limp whistleblower policies in Indian corporates with possible conflict of interest patterns
Indian Express / December 2014
Data obtained from U.S. FDA under U.S.' FOIA shows the fears surrounding Indian generic drugmaker compliance may be overstated
Indian Express / January 2014
Here are some of the other writers who are using porterfolio right now.